ExeonTrace protects trade secrets and sensitive patient data

The average cost of a data breach in the pharma industry is $5.01 million (2022)

The development of new drugs is time and resource-intensive. Most of the research leverages proprietary compounds and sensitive techniques that form the foundation of trade secrets. However, protecting intellectual property and trade secrets continues to be a massive challenge for pharmaceutical and life science enterprises.

Intellectual property like clinical trial data, new product formulas, and test results must be guarded with cutting-edge security technology. After all, the stakes cannot be any higher with multi-billion euros of research at risk. Furthermore, sensitive data like patient information from participants in new drug trials must be adequately secured to ensure privacy and regulatory compliance.

In this scenario, traditional cyber prevention measures simply do not cut it. Pharmaceutical and life sciences companies require security solutions that immediately detect suspicious behaviour in the cloud and in on-site corporate networks in order to detect potential attacks before they harm the companies concerned.

Major pharma and life science companies
Major pharma and life science companies

build on ExeonTrace because:

ExeonTrace is deployed in the network infrastructure of the client
All data remains in the company infrastructure
No third-party devices are needed
ExeonTrace is deployed on a very short notice, allowing for immediate visibility, detection and response
ExeonTrace complies with specific pharmaceutical and life science regulations

Life sciences and pharma focus

Integrated rights and supply chain management

Many pharmaceutical companies collaborate extensively with scientists, academic research institutions, partners, and more to optimise resources and the development process. However, collaboration significantly increases your risk exposure for cyber attacks. Whether sensitive data is shared internally or externally, it must remain secured through the sharing cycle and beyond.

Patient and trial data security

It is critical to protect sensitive patient data to ensure privacy and compliance. As cyber criminals relentlessly target patient data and sensitive personal information, the life sciences sector must go above and beyond to proactively secure data while being alert to a potential breach.

Maintaining strict regulatory compliance

Healthcare institutions, pharmaceutical companies, and life science businesses are required to maintain strict compliance. However, this becomes increasingly challenging when you consider the increasingly complex business operations. To cope with this increasing complexity, the industry must be able to ensure real-time monitoring and alerting of networks.

Data segregation and internal barriers

Protecting intellectual property also includes activity monitoring and controls. This is vital to keeping trade secrets surrounding the drug design process within a highly secure ecosystem and only accessed by authorised personnel. This also includes protecting information from hidden threats while data is transferred or uploaded to designated repositories.

Why ExeonTrace

Rapid Deployment

Software-based. No sensors or agents needed. Ready in hours.

Total Visibility

Through the integration of ExonTrace all sites and networks can be monitored. With the algorithm-driven threat scoring, the network is constantly monitored and advanced attacks are immediately reported by an alert.

Vigorous Detection

Powerful AI and proven algorithms, based on over a decade of research at ETH Zürich.

Effective Response

Quick threat assessment, investigation & hunting.

Clever Data Handling

Flow data collection (NetFlow) from different locations distributed all over the world. Using NetFlow data makes the solution very lightweight, reducing the bandwidth needed for the analysis.

Future-Proof

Ready for ever-increasing network traffic and encryption.

Trusted by

WinGD
SWISS
PostFInance
Planzer
SoH

As CEO and owner of a fast moving logistics company, I cannot afford any system interruptions due to cyber incidents. With ExeonTrace, we have found a Swiss solution to monitor our network and quickly detect cyber threats.

Nils Planzer CEO & Owner Planzer
Nils Planzer